6 days Ago By ABMN Staff
Franklin Resources Inc. grew its holdings in Prestige Consumer Healthcare Inc. ( NYSE:PBH – Free Report ) by 0.
7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 21,735 shares of the company’s stock after acquiring an additional 150 shares during the period. Franklin Resources Inc.
’s holdings in Prestige Consumer Healthcare were worth $1,697,000 as of its most recent SEC filing. A number of other hedge funds have also recently modified their holdings of PBH. Kestra Investment Management LLC purchased a new position in Prestige Consumer Healthcare during the fourth quarter valued at approximately $27,000.
CIBC Private Wealth Group LLC boosted its holdings in Prestige Consumer Healthcare by 48.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company’s stock worth $34,000 after buying an additional 152 shares during the period.
GAMMA Investing LLC increased its stake in Prestige Consumer Healthcare by 18.9% in the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after buying an additional 220 shares in the last quarter.
KBC Group NV raised its holdings in Prestige Consumer Healthcare by 28.3% during the fourth quarter. KBC Group NV now owns 2,048 shares of the company’s stock valued at $160,000 after acquiring an additional 452 shares during the period.
Finally, Blue Trust Inc. lifted its position in shares of Prestige Consumer Healthcare by 24.8% in the fourth quarter.
Blue Trust Inc. now owns 2,190 shares of the company’s stock valued at $158,000 after acquiring an additional 435 shares in the last quarter. Institutional investors own 99.
95% of the company’s stock. Analyst Upgrades and Downgrades PBH has been the subject of several research analyst reports. Royal Bank of Canada increased their target price on Prestige Consumer Healthcare from $96.
00 to $97.00 and gave the stock a “sector perform” rating in a research report on Friday, March 21st. DA Davidson lifted their price objective on shares of Prestige Consumer Healthcare from $95.
00 to $104.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Canaccord Genuity Group upped their target price on shares of Prestige Consumer Healthcare from $93.
00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Oppenheimer raised their target price on shares of Prestige Consumer Healthcare from $87.
00 to $93.00 and gave the company an “outperform” rating in a research note on Thursday, February 13th. Finally, StockNews.
com cut shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday, April 8th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.
com, Prestige Consumer Healthcare has a consensus rating of “Hold” and an average price target of $93.33. Prestige Consumer Healthcare Price Performance PBH stock opened at $82.
13 on Tuesday. Prestige Consumer Healthcare Inc. has a 52 week low of $62.
35 and a 52 week high of $90.04. The firm has a market capitalization of $4.
07 billion, a P/E ratio of 19.23, a price-to-earnings-growth ratio of 2.69 and a beta of 0.
47. The company has a fifty day simple moving average of $84.69 and a two-hundred day simple moving average of $79.
97. The company has a quick ratio of 2.20, a current ratio of 3.
68 and a debt-to-equity ratio of 0.56. Prestige Consumer Healthcare ( NYSE:PBH – Get Free Report ) last announced its quarterly earnings results on Thursday, February 6th.
The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.
04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.
36%. Analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.
5 earnings per share for the current fiscal year. Insider Activity In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction on Monday, March 10th. The shares were sold at an average price of $90.
00, for a total transaction of $151,020.00. Following the completion of the transaction, the senior vice president now directly owns 17,157 shares of the company’s stock, valued at $1,544,130.
The trade was a 8.91 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink .
Corporate insiders own 1.60% of the company’s stock. Prestige Consumer Healthcare Profile ( Free Report ) Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally.
The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. Further Reading Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter .
.
